Drugs / hydrocortison hemisuccinate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT01817153 Comparator | Nov 2013 → Nov 2019 | infectious disease with sepsis | Centre Hospitalier Régional d'Orléans | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hydrocortison hemisuccinate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01817153 ↗ |
| Route | Intravenous | “50 mg hydrocortison iv” NCT01817153 ↗ |